167PS Setting New Horizons In Optimizing Guideline Utility

Background To maximise uptake, CPG recommendations must avoid of bias and be responsive to the needs of clinicians and patients from different populations and settings. Objectives/Goal To discuss three key challenges to CPG use: 1) building consensus and minimising conflicts of interest in formulating recommendations for specific patient populations; 2) taking account of patient multi-morbidity; 3) incorporating patient values and preferences for specific outcomes. Target group Suggested audience Guideline developers and writing groups, clinical researchers, users of guidelines (clinicians, patients). Moderator Prof Ian A Scott, Director of Internal Medicine and Clinical Epidemiology, Princess Alexandra Hospital, Brisbane, Australia. Invited Speakers Dr Susan L Norris, Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, USA. SLN is Technical Officer for the secretariat of the Guideline Review Committee at the World Health Association in Geneva, Switzerland and has conducted research on conflicts of interest. Professor Holger J Schunemann, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. HJS is co-chair of the GRADE working group, member of the GIN board of trustees and has co-authored reports on guideline methodology, including multimorbidity. Professor Gordon H Guyatt, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. GHG is co-chair of the GRADE working group and chaired the executive of 9th iteration of the American College of Chest Physicians Antithrombotic Guidelines. Description of session and speaker topics Session will comprise 3 presentations (15 mins), one for each challenge, with 5 mins for questions of clarification then 30 mins of panel discussion.